Analyst Recommendations

HSBC analyst issues BUY recommendation on MCD at 2023-09-07 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the MCD was...

September 7, 2023   MCD 1.97%

HSBC analyst issues HOLD recommendation on MCD at 2023-09-07 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the MCD was...

September 7, 2023   MCD 1.97%

JMP Securities analyst issues MARKET PERFORM recommendation on AKTS at 2023-09-07 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the

September 7, 2023   AKTS -5.49%

Barclays analyst issues OVERWEIGHT recommendation on CHPT at 2023-09-07 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the CHPT was...

September 7, 2023   CHPT 5.29%

Raymond James analyst issues OUTPERFORM recommendation on CHPT at 2023-09-07 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the CHPT...

September 7, 2023   CHPT 5.29%

B. Riley analyst issues BUY recommendation on AKTS at 2023-09-07 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the AKTS...

September 7, 2023   AKTS -5.49%

Barclays analyst issues UNDERWEIGHT recommendation on AKTS at 2023-09-07 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the AKTS was...

September 7, 2023   AKTS -5.49%

B. Riley Securities analyst issues BUY recommendation on VRNT at 2023-09-07 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the

September 7, 2023   AKTS -5.49%

Lake Street analyst issues BUY recommendation on VRNT at 2023-09-07 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the VRNT...

September 7, 2023   AKTS -5.49%

Citigroup analyst issues BUY recommendation on PHR at 2023-09-07 11:00:00. The previous analyst recommendation was Buy.At the time of the issue of the analyst recommendation, the PHR was...

September 7, 2023   PHR 10.30%